SavedAdd your journal

Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2012 / Cilt: 46 - Sayı: 1

Topical dimethylsulfoxide: Successful treatment of a case of localized cutaneous mucinosis

Topikal dimetil sülfoksit: Başarılı bir “Lokalize deri müsinozu” tedavisi

Sinem YAPRAK KARAVANA
Tuğrul DERELİ
Meltem TÜRKMEN
Bengü GERÇEKER TÜRK
İlgen ERTAM
Pages
53–54
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report a case of localized cutaneous mucinosis who have been treated successfully with topical 50% dimethyl sulfoxide bioadehesive gel.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cutaneous mucinoses is a connective tissue disorder characterized by the abnormal deposition of mucin in the dermis.
📊
Key Findings & Data:Treatment of the disorder is limited only to case reports because of the rarity of the disease.
💡
Conclusion & Impact:Herein, we report a case of localized cutaneous mucinosis who have been treated successfully with topical 50% dimethyl sulfoxide bioadehesive gel.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cutaneous mucinoses is a connective tissue disorder characterized by the abnormal deposition of mucin in the dermis. Treatment of the disorder is limited only to case reports because of the rarity of the disease. The literature about the usage of dimethyl sulfoxide in cutaneous mucinosis is limited only to a case report of scleromxyedema treated by oral administration of the chemical. Herein, we report a case of localized cutaneous mucinosis who have been treated successfully with topical 50% dimethyl sulfoxide bioadehesive gel.

Özet

Deri müsinozu, dermiste anormal müsin birikimi ile karakterize bir konnektif doku hastalığıdır. Hastalığın nadir görülmesinden dolayı hastalığın tedavisi sadece olgu bildirimleri ile sınırlıdır. Literatürde dimetil sülfoksitin deri müsinozu tedavisindeki kullanımı, oral dimetil sülfoksitin ile tedavi edilen bir skleromiksödem olgusu ile sınırlıdır Burada %50 dimetil sülfoksit jelin topikal kullanımı ile başarılı sonuç alınmış bir lokalize deri müsinozu olgusu sunulmaktadır.

🔖

Cite This Article

KARAVANA, S. Y., DERELİ, T., TÜRKMEN, M., TÜRK, B. G., ERTAM, İ. (2022). Topical dimethylsulfoxide: Successful treatment of a case of localized cutaneous mucinosis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 46 - Sayı: 1, 53–54. https://ajindex.com/articles/621967

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Tschen JA, Chang JR: Scleromyxedema: treatment with interferon alfa. J Am Acad Dermatol 1999;40:303-7
  2. Rongioletti F, Rebora A: Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001;44:273-81
  3. Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR: Scleromyxedema. Clin Dermatol 2006;24:493-7
  4. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular and molecular aspects. Biochem Pharmacol 2003;65:1035-41
  5. Ozkaya-Bayazit E, Kavak A, Güngör H, Ozarmagan G. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis. Int J Dermatol 1998;37:949-54
  6. Pandhi R, Kaur I, Kumar B. Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat 2002;13:11-4
  7. Bonnetblanc JM, Bedane C. Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up. Arch Dermatol 1991;127:1733-4.